Mercury Bio is developing a next-generation biomolecular drug delivery platform. Using a novel system for drug encapsulation in natural vesicles, their technology enhances drug efficacy while reducing side effects by employing cell-specific targeting. The result is a next-generation drug delivery system in a scalable, low-cost production platform that will unlock the potential of RNA therapeutics and small molecule drugs.
